share_log
Moomoo 24/7 ·  04/04 07:53

Unicycive Therapeutics Shares Are Trading Higher After Piper Sandler Initiated Coverage on the Stock With an Overweight Rating and a Price Target of $9

派珀·桑德勒开始对Unicycive Therapeutics进行增持评级,目标股价为9美元,此后,Unicycive Therapeutics的股价走高

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发